newsfilter
← Latest News
GlobeNewswire·

AccuStem Sciences, Inc. Announces Acquisition of Proprietary MSC Lung Cancer Screening Test

AccuStem pursuing strategic commercialization plan intending to launch the MSC test in the US in 2026 LONDON and PHOENIX, Ariz., March 18, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB:ACUT), a clinical